Methicillin-resistant Staphylococcus aureus nosocomial acquisition and carrier state in a wound care center

Archives of Dermatology

Volumn 136, Issue 6, 2000, Pages 735-739

  Kac, Guillaume ^a   Buu Hoï, Annie ^a   Herisson, Elisabeth ^a   Biancardini, Patricia ^a   Debure, Clélia ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ADULT; AGED; ARTICLE; BACTERIUM CARRIER; CONTROLLED STUDY; DISEASE TRANSMISSION; HAND WASHING; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RISK FACTOR; SKIN INJURY; WOUND INFECTION;

EID: 0034130827     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.136.6.735     Document Type: Article

References (23)

1. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis. 1995;2:1308-1312.
2. Panlilio A, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals. 1975-1991. Infect Control Hosp Epidemiol. 1992;13:582-586.
3. Collège de Bactèriologie-Virologie-Hygiéne du Centre Hospitalier Universitaire de Paris. Surveillance des staphylocoques dorés et klebsielles multi-résistanis à l'Assistance Publique-hôpitaux de Paris (1993-96). Bull Epidemiol Hebdo. 1998; 10:41-43.
4. Richet H, Wiesel M, Le Gallou F, André-Richet B, Espaze E. Methicillin-resistant Staphylococcus aureus control in hospitals: the French experience. Infect Control Hosp Epidemiol. 1996;17:509-511.
5. Lowy FD. Staphylococcus aureus infections. N Engl J Wed. 1998;339:520-532.
6. Wakefield DS, Helms CM, Massanari RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control. 1988;16:185-192.
7. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med. 1993; 94:313-328.
8. Jarlier V. Surveillance en France: klebsielles et staphylocoques multirésistants: stratégie de prévention à l'AP-HP. Bull Epidemiol Hebdo. 1993;42:192-193.
9. Ayliffe GAJ. Recommendations for the Control of Methicillin-Resistant Staphylococcus aureus (MRSA). Geneva, Switzerland: World Health Organization; 1996: 1-28.
10. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med. 1991;115:417-422
11. Coello R, Glynn JR, Caspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect. 1997;37:39-46.
12. Bradley SF. Methicillin-resistant Staphylococcus aureus in nursing homes: epidemiology, prevention and management. Drugs Aging. 1997;10:185-198.
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. 1988. Am J Infect Control 1988;16:128-140.
14. Acar J, Bergogne-Bérézin E, Chabbert Y, et al. Communiqué 1992 du Comité de l'Antibiogramme de la Société Française de Microbiologie. Pathol Biol (Paris). 1992;40:741-748
15. Casewell MW. Epidemiology and control of the "modern" methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1986;7(suppl A):1-11.
16. Girou E, Wolkenstein P, Oppein F, et al. Suivi d'une politique de lutte contre les staphylocoques dorés méticilline-résistants dans une unité de soins intensifs de dermatologie. Ann Dermatol Venereol. 1996;123(suppl 1):S16-S17.
17. Rodier L, de Wit D. MRSA colonization rates of readmitted patients previously colonized or infected with MRSA. J Hosp Infect. 1997;35:161-163.
18. Girou E. Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1998;27:543-550.
19. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Clinical experience and outcomes of community-acquired and nosocomial MRSA in a northern Australian hospital. J Hosp Infect. 1998;38:273-281
20. Hansson C. Microbial flora in venous leg ulcers and choice of treatment. In: Treatment of Ulcers. Oslo, Norway: Sandberg AS: 1995:139-148.
21. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993; 328:1676-1684.
22. Bonten MJM, Weinstein RA. The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol. 1996;17:193-200.
23. Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol. 1992;13:725-737.